michigan semaglutide diarrhea lawsuit Ozempic Lawyer in Kentucky SIDE EFFECTS OF GLP-1s: WRTV
Description
Thomas Aretz
Semaglutide, the active ingredient in Novo Nordisks blockbuster diabetes and weight-loss medications Ozempic and Wegovy, has been on the FDAs shortage list since March 2022
More than 40 Indian pharmaceutical companies are preparing to launch over 50 branded versions of the drug almost simultaneously, in what analysts describe as one of the most crowded generic launches in Indian pharma history
Diabetes Care , 43 (2), 487-493
Providers typically recommend spacing doses and adjusting treatment carefully to avoid overlap
